Patent: 7,998,734
✉ Email this page to a colleague
Summary for Patent: 7,998,734
Title: | Methods and compositions for use in gene therapy for treatment of hemophilia |
Abstract: | The invention includes a composition comprising a recombinant adeno-associated viral vector comprising at least two adeno-associated virus inverted terminal repeats, a promoter/regulatory sequence, isolated DNA encoding Factor IX and accompanying 5\' and 3\' untranslated regions and a transcription termination. |
Inventor(s): | High; Katherine A. (Merion, PA), Herzog; Roland W. (Glenolden, PA) |
Assignee: | The Children\'s Hospital of Philadelphia (Philadelphia, PA) |
Application Number: | 11/932,017 |
Patent Claims: | see list of patent claims |
Details for Patent 7,998,734
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2017-03-14 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2017-03-14 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2017-03-14 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |